Related Experiment Video
Updated: Nov 3, 2025

Noninvasive Sampling of Mucosal Lining Fluid for the Quantification of In Vivo Upper Airway Immune-mediator Levels
Published on: August 7, 2017
Future Biomarkers for Infection and Inflammation in Febrile Children
Judith Zandstra1,2, Ilse Jongerius1,2, Taco W Kuijpers2,3
1Division Research and Landsteiner Laboratory, Department of Immunopathology, Sanquin Blood Supply, Amsterdam University Medical Center (UMC), Amsterdam, Netherlands.
Insights
New biomarkers help diagnose fevers from infections or inflammation. Combination tests using protein markers or transcriptomic analysis show promise for faster, tailored patient treatment.
Area of Science:
- Biomedical diagnostics
- Molecular biology
- Clinical pathology
Background:
- Febrile illnesses often present with overlapping symptoms, complicating accurate diagnosis.
- Distinguishing between infection, inflammation, and autoimmune conditions is clinically challenging.
- Effective patient management requires timely and precise etiological diagnosis.
Purpose of the Study:
- To review novel biomarkers and discovery approaches for febrile conditions.
- To assess current methods for differentiating infectious from non-infectious causes of fever.
- To evaluate the potential of combined biomarker strategies in clinical diagnostics.
Main Methods:
- Review of current plasma and whole blood biomarkers.
- Analysis of RNA profiling and mass spectrometry data for infection discrimination.
- Evaluation of biomarker utility in distinguishing infectious from non-infectious inflammatory diseases.
Main Results:
- Current plasma and whole blood biomarkers show potential in differentiating bacterial and viral infections.
- Biomarker approaches are being developed to distinguish infectious from non-infectious inflammatory conditions.
- Combination tests, including protein markers and transcriptomic analysis, demonstrate significant advancements.
Conclusions:
- Combined biomarker signatures, particularly using transcriptomic analysis, offer a promising avenue for improved febrile illness diagnostics.
- Further exploration of these combination tests is crucial for accelerating early and tailored treatment decisions.
- Advanced biomarker strategies can significantly enhance patient outcomes by enabling precise diagnosis and timely intervention.
Abstract:
Febrile patients, suffering from an infection, inflammatory disease or autoimmunity may present with similar or overlapping clinical symptoms, which makes early diagnosis difficult. Therefore, biomarkers are needed to help physicians form a correct diagnosis and initiate the right treatment to improve patient outcomes following first presentation or admittance to hospital. Here, we review the landscape of novel biomarkers and approaches of biomarker discovery. We first discuss the use of current plasma parameters and whole blood biomarkers, including results obtained by RNA profiling and mass spectrometry, to discriminate between bacterial and viral infections. Next we expand upon the use of biomarkers to distinguish between infectious and non-infectious disease. Finally, we discuss the strengths as well as the potential pitfalls of current developments. We conclude that the use of combination tests, using either protein markers or transcriptomic analysis, have advanced considerably and should be further explored to improve current diagnostics regarding febrile infections and inflammation. If proven effective when combined, these biomarker signatures will greatly accelerate early and tailored treatment decisions.
Related Concept Videos
Increased Body Temperature
Methods of reducing fever
Pharmacological Methods of Reducing Fever:
Patterns of Fever

